3 Patents
- US125839032026Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Abelzeta Inc.
0 cites - US116187782023Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
CELLULAR BIOMEDICINE GROUP Inc.
0 cites - US116083692023Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Cellular Biomedicine Group, Inc.
0 cites